Resistance, fitness, adherence, and potency - Mapping the paths to virologic failure

被引：37

作者：

Markowitz, M ^{[1
]}

机构：

[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2000年 / 283卷 / 02期

关键词：

D O I：

10.1001/jama.283.2.250

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：250 / 251

页数：2

共 14 条

[1] Human immunodeficiency virus drug therapy and virus load [J].

Bonhoeffer, S ;

Coffin, JM ;

Nowak, MA .

JOURNAL OF VIROLOGY, 1997, 71 (04) :3275-3278

[2] IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS [J].

CONDRA, JH ;

SCHLEIF, WA ;

BLAHY, OM ;

GABRYELSKI, LJ ;

GRAHAM, DJ ;

QUINTERO, JC ;

RHODES, A ;

ROBBINS, HL ;

ROTH, E ;

SHIVAPRAKASH, M ;

TITUS, D ;

YANG, T ;

TEPPLER, H ;

SQUIRES, KE ;

DEUTSCH, PJ ;

EMINI, EA .

NATURE, 1995, 374 (6522) :569-571

[3] Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy [J].

Descamps, D ;

Flandre, P ;

Calvez, V ;

Peytavin, G ;

Meiffredy, V ;

Collin, G ;

Delaugerre, C ;

Robert-Delmas, S ;

Bazin, B ;

Aboulker, JP ;

Pialoux, G ;

Raffi, F ;

Brun-Vézinet, F .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (02) :205-211

[4] Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy [J].

Furtado, MR ;

Callaway, DS ;

Phair, JP ;

Kunstman, KJ ;

Stanton, JL ;

Macken, CA ;

Perelson, AS ;

Wolinsky, SM .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) :1614-1622

[5] Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens [J].

Havlir, DV ;

Hellmann, NS ;

Petropoulos, CJ ;

Whitcomb, JM ;

Collier, AC ;

Hirsch, MS ;

Tebas, P ;

Sommadossi, JP ;

Richman, DD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (02) :229-234

[6] Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy [J].

Havlir, DV ;

Marschner, IC ;

Hirsch, MS ;

Collier, AC ;

Tebas, P ;

Bassett, RL ;

Ioannidis, JPA ;

Holohan, MK ;

Leavitt, R ;

Boone, G ;

Richman, DD .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (18) :1261-1268

[7] HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter [J].

Lee, CGL ;

Gottesman, MM ;

Cardarelli, CO ;

Ramachandra, M ;

Jeang, KT ;

Ambudkar, SV ;

Pastan, I ;

Dey, S .

BIOCHEMISTRY, 1998, 37 (11) :3594-3601

[8] Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1 infected individuals on prolonged effective antiretroviral therapy [J].

Lewin, SR ;

Vesanen, M ;

Kostrikis, L ;

Hurley, A ;

Duran, M ;

Zhang, L ;

Ho, DD ;

Markowitz, M .

JOURNAL OF VIROLOGY, 1999, 73 (07) :6099-6103

[9] Ordered accumulation of mutations in HIV protease confers resistance to ritonavir [J].

Molla, A ;

Korneyeva, M ;

Gao, Q ;

Vasavanonda, S ;

Schipper, PJ ;

Mo, HM ;

Markowitz, M ;

Chernyavskiy, T ;

Niu, P ;

Lyons, N ;

Hsu, A ;

Granneman, GR ;

Ho, DD ;

Boucher, CAB ;

Leonard, JM ;

Norbeck, DW ;

Kempf, DJ .

NATURE MEDICINE, 1996, 2 (07) :760-766

[10]

PERELSON AS, 1997, AIDS SA, P17

← 1 2 →